A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts.
Andrea OssatoValeria MezzadrelliGiulia MontagnerDiletta TrojanGiuseppe GiovagnoniMichele GianniniCarlotta TrabucchiChiara AngeliniFrancesca RealdonLorenza CiprianoNicola RealdonTeresa ZuppiniRoberto TessariPublished in: European journal of hospital pharmacy : science and practice (2023)
This study shows how the centralised processing of human tissues in the hospital pharmacy makes the procedure safer and more efficient, demonstrating how the synergy between different hospital departments, high professional skills and ethics can lead to a clinical advantage for patients and a better economic impact for the hospital.
Keyphrases
- healthcare
- endothelial cells
- acute care
- adverse drug
- gene expression
- newly diagnosed
- end stage renal disease
- ejection fraction
- chronic kidney disease
- induced pluripotent stem cells
- pluripotent stem cells
- emergency department
- minimally invasive
- deep learning
- electronic health record
- machine learning
- artificial intelligence